I chose to work at Ohio State for many reasons. As an Ohio native, I take pride in our state and its people. When I was a medical student, a family member came to Ohio State and received excellent care. I was impressed with the physician’s ability and compassion. I wanted to be a part of that.
I've always appreciated how procedures like refraction and cataract surgery improve vision. But I was drawn to multifaceted ocular diseases, such as glaucoma. I enjoy the long-term relationships with patients and families as I work with them throughout their treatment.
Preventing vision loss is rewarding. I screen patients to see if they have early signs of glaucoma or other diseases. Early detection helps prevent vision loss.
My patients receive the best possible care. My goal is to give them a thorough eye exam, explain what’s going on, address any fears and answer all of their questions.
- Developing new targeted glaucoma therapies
- Co-authored book chapters on glaucoma
- Research interests include glaucoma, ocular hypertension and imaging
Northeastern Ohio Universities College of Medicine
Callahan Eye Foundation Hospital
7/1/2007 - 6/30/2010
Specialties and conditions I treat
- Eyelid Diseases
- Diabetic Retinopathy
- Optic Nerve Diseases
- Eye Injuries
- Hypertensive Retinopathy
- Optic Nerve Injuries
- Eye Hemorrhage
- Conjunctivitis, Bacterial
- Keratoconjunctivitis, Infectious
- Conjunctivitis, Viral
- Eye Pain
- Optic Atrophy
- Optic Disk Drusen
- Optic Neuropathy, Ischemic
- Exfoliation Syndrome
- Iridocorneal Endothelial Syndrome
- Optic Atrophies, Hereditary
- Wolfram Syndrome
- Optic Atrophy, Autosomal Dominant
- Optic Atrophy, Hereditary, Leber
- Glaucoma, Angle-Closure
- Glaucoma, Neovascular
- Glaucoma, Open-Angle
- Low Tension Glaucoma
- Ocular Hypertension
- Ocular Hypotension
Locations where I practice
More about my work
Wills Eye Hospital
7/1/2010 - 6/30/2011
American Board of Ophthalmology
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/17, Dr. Jain has reported no financial relationships with medical device, research and/or drug companies.